17 Clinical Trials Sponsored by “Max-Planck-Institute of Psychiatry”, Page 1 of 2

1 2

Hide Studies Not Open or Pending

2

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Condition(s):Schizophrenia; Schizotypal Disorder; Delusional Disorder; Brief Psychotic Disorder; Shared Psychotic Disorder; Schizoaffective Disorder; Other Psychotic Disorder Not Due to A Substance or Known Physiological Condition; Unspecified Psychosis Not Due to a Substance or Known Physiological Condition; Manic Episode, Severe With Psychotic Symptoms; Bipolar Disorder, Current Episode Manic Severe With Psychotic Features; Bipolar Disorder, Current Episode Depressed, Severe, With Psychotic Features; Major Depressive Disorder, Single Episode, Severe With Psychotic Features; Major Depressive Disorder, Recurrent, Severe With Psychotic SymptomsLast Updated:October 23, 2023Completed

1 2

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.